[1] Loos R J. The genetics of adiposity[J]. Curr Opin Genet Dev, 2018, 50:86-95. [2] Ying W, Riopel M, Bandyopadhyay G, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity[J]. Cell, 2017, 171(2):372-384. [3] Shen L, Gan M, Li Q, et al. MicroRNA-200b regulates preadipocyte proliferation and differentiation by targeting KLF4[J]. Biomed Pharmacother, 2018, 103:1538-1544. [4] Chen D, Wang Y, Wu K, et al. Dual effects of metformin on adipogenic differentiation of 3T3-L1 preadipocyte in aMPK-Dependent and independent manners[J]. Int J Mol Sci, 2018, 19(6):pii. [5] Chen J, Liu Y, Lu S, et al. The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation[J]. Int J Obes:(Lond), 2017, 41(2):299-308. [6] Rabiee A, Schwammle V, Sidoli S, et al. Nuclear phosphoproteome analysis of 3T3-L1 preadipocyte differentiation reveals system-wide phosphorylation of transcriptional regulators[J]. Proteomics, 2017, 17(6). [7] Adaikalakoteswari A, Vatish M, Alam M T, et al. Low vitamin B12 in pregnancy is associated with adipose-derived circulating miRs targeting PPAR gamma and insulin resistance[J]. J Clin Endocrinol Metab, 2017, 102(11):4200-4209. [8] Chandra M, Miriyala S, Panchatcharam M. PPARgamma and its role in cardiovascular diseases[J]. PPAR Res, 2017, 2017:6404638. [9] Peng J, Li Y, Wang X, et al. An Hsp20-FBXO4 axis regulates adipocyte function through modulating PPAR gamma ubiquitination[J]. Cell Rep, 2018, 23(12):3607-3620. [10] Puhl A C, Milton F A, Cvoro A, et al. Mechanisms of peroxisome proliferator activated receptor gamma regulation by non-steroidal anti-inflammatory drugs[J]. Nucl Recept Signal, 2015, 13:e004. |